Home › Medulloblastoma › Minnesota
Medulloblastoma clinical trials in Minnesota
3 studies for Medulloblastoma are looking for participants at sites in Minnesota.
Cities in Minnesota
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
- Children's Hospital and Clinics of Minnesota, Minneapolis
RecruitingPhase 2
59 Months · All sexes · Updated Sep 15, 2026 · NCT05535166A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
- Mayo Clinic in Rochester, Rochester
RecruitingPhase 3
Ages 4 to 21 · All sexes · Updated Aug 25, 2026 · NCT05382338Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma
- Children's Minnesota, Minneapolis
Recruiting
12 Months – 39 Years · All sexes · Updated Aug 11, 2026 · NCT05057702From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.